What is the timeline for administering the 1st and 2nd tuberculin skin test (TST) or interferon-gamma release assay (IGRA) in a two-step TB testing protocol for individuals with a high risk of exposure or history of TB exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Two-Step TB Testing Timeline

For the two-step tuberculin skin test (TST) protocol, administer the first test on Day 0, read it at 48-72 hours (Day 2-3), then place the second test 1-3 weeks after reading the first test (approximately Day 9-24), and read it again at 48-72 hours. 1

Purpose of Two-Step Testing

The two-step TST protocol specifically detects the "booster phenomenon" in individuals with waned TB immunity, preventing misinterpretation of boosted reactions as new infections during subsequent serial testing. 1 This is critical because:

  • Without two-step testing, a boosted reaction on later testing might be incorrectly classified as a new TB conversion, triggering unnecessary contact investigations and preventive therapy. 1
  • The booster effect occurs when an initial TST "reminds" the immune system of prior TB exposure or BCG vaccination, causing a stronger reaction on the second test that reflects old—not new—infection. 1

Who Requires Two-Step Testing

Two-step testing should be performed on all newly employed healthcare workers who have an initial negative TST and no documented negative TST within the preceding 12 months. 1 This applies to:

  • Healthcare workers in facilities conducting periodic TB screening 1
  • Staff in correctional institutions and nursing homes 1
  • Populations with high rates of prior TB exposure or BCG vaccination 1
  • Older adults, who demonstrate the booster phenomenon more frequently 1

Detailed Timeline Protocol

First Test

  • Day 0: Place the first TST using the Mantoux technique (0.1 mL of 5 tuberculin units intracutaneously on the forearm) 1
  • Day 2-3 (48-72 hours): Read the first test by measuring only the induration (hardened area), not erythema 1

Second Test

  • Day 9-24 (1-3 weeks after first reading): Place the second TST 1
  • 48-72 hours later: Read the second test 1

Critical Timing Considerations

The interval between the first and second test must be 1-3 weeks. 1 Improper timing affects accuracy:

  • Testing too soon (less than 1 week) can interfere with the immunological response and produce inaccurate results 2
  • Testing beyond 3 weeks may miss the optimal window for detecting the booster phenomenon 1

Interpretation of Two-Step Results

  • Both tests negative: True negative baseline established; individual can proceed with annual or periodic screening as indicated by risk classification 3
  • First test negative, second test positive: This represents a boosted reaction from prior TB exposure or BCG vaccination, not a new infection 1
  • First test positive: No second test needed; proceed with evaluation for latent TB infection or active disease 1

Common Pitfalls to Avoid

  • Failure to implement two-step testing in appropriate populations leads to misclassification of boosted reactions as new infections, particularly problematic in healthcare settings with serial testing programs. 1
  • Reading tests outside the 48-72 hour window reduces accuracy and should be avoided. 1
  • Measuring erythema instead of induration leads to incorrect interpretation; only the palpable, raised, hardened area should be measured in millimeters. 1
  • Performing the second test too soon (less than 1 week) interferes with immune response and yields unreliable results. 2

Alternative Considerations

For individuals unlikely to return for multiple visits, interferon-gamma release assays (IGRAs) may be considered as they require only a single blood draw without return visits for reading. 3 However, guidelines vary internationally on IGRA use, with some recommending TST followed by IGRA for confirmation in BCG-vaccinated individuals, while others suggest either test alone. 3

References

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Timing of TB Skin Test After Live Vaccine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.